2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.

2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.

<h4>Introduction</h4>Duration of antibiotic treatment in acute exacerbation of COPD (AECOPD) is most commonly based on expert opinion. Biomarker guided strategy is increasingly recommended to limit unnecessary antibiotic use. We performed a randomized controlled study to evaluate the eff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Msolli Mohamed Amine, Messous Selma, Sekma Adel, Bel Haj Ali Khaoula, Khalil Mohamed Hassene, Trabelsi Imen, Abdelghani Ahmed, Ben Brahim Nadia, Ben Dhaya Yosra, Razgallah Rabie, Grissa Mohamed Habib, Beltaief Kaouthar, Methamem Mehdi, Belguith Asma, Bouida Wahid, Boukef Riadh, Boubaker Hamdi, Nouira Semir, GREAT Network
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/b7b71fcf55b14baaa16d578a205d8626
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b7b71fcf55b14baaa16d578a205d8626

Ejemplares similares